This report provides a comprehensive analysis of the global sodium citrate erythrocyte sedimentation tube market, tracing its trajectory through 2032. It examines key segments including glass and PET plastic types, while evaluating applications across hospitals and medical laboratories. The study explores critical market dynamics, regional growth patterns in the Americas, APAC, and Europe, and the competitive landscape featuring major players like Becton Dickinson and Greiner Bio-One to identify emerging opportunities and strategic trends.

Market Overview

The global Sodium Citrate Erythrocyte Sedimentation Tube market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Product Definition and Functionality

Sodium citrate erythrocyte sedimentation tube is a medical test tool used to measure the erythrocyte sedimentation rate (ESR). The tubes are pre-loaded with sodium citrate anticoagulant to prevent blood clotting and ensure that red blood cells can naturally settle within a specific timeframe. This test is primarily utilized to evaluate the presence of inflammation, infection, or other diseases within the body, as changes in the red blood cell sedimentation rate can reflect the body's inflammatory response or overall disease state.

Regional Market Analysis

• United States: The market for Sodium Citrate Erythrocyte Sedimentation Tube in the United States is estimated to increase from 2025 through 2032, following a consistent growth trajectory.
• China: The market for Sodium Citrate Erythrocyte Sedimentation Tube in China is estimated to increase from 2025 through 2032, following a consistent growth trajectory.
• Europe: The market for Sodium Citrate Erythrocyte Sedimentation Tube in Europe is estimated to increase from 2025 through 2032, following a consistent growth trajectory.

Market Segmentation

By Type

• Glass
• PET Plastic

By Application

• Hospital
• Medical Laboratory
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Key Industry Players

The following companies have been profiled based on primary expert input and analysis of company coverage, product portfolios, and market penetration:

• Becton Dickinson
• Greiner Bio-One
• FL MEDICAL
• KS Medical
• Deltalab
• Orsin Medical Technology
• Xinkang Medical
• Xiangyuan Medical
• Tedia Medical Instruments
• Boon Medical Supply
• Improve Medical
• Ardent Biomed
• Gongdong Medical

Market Concentration

In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

About the Report

Research Scope and Methodology

LP Information, Inc. (LPI)'s newest research report, the “Sodium Citrate Erythrocyte Sedimentation Tube Industry Forecast,” reviews total world Sodium Citrate Erythrocyte Sedimentation Tube sales in 2025 and provides a comprehensive analysis of projected sales for 2026 through 2032. The report provides a detailed analysis in US$ millions, with sales broken down by region, market sector, and sub-sector.

This Insight Report provides a comprehensive analysis of the global Sodium Citrate Erythrocyte Sedimentation Tube landscape, highlighting key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their Sodium Citrate Erythrocyte Sedimentation Tube portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating global market.

Using a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study evaluates key market trends, drivers, and affecting factors. The forecast is broken down by Type, Application, geography, and market size to highlight emerging pockets of opportunity.

Key Questions Addressed

• What is the 10-year outlook for the global Sodium Citrate Erythrocyte Sedimentation Tube market?
• What factors are driving Sodium Citrate Erythrocyte Sedimentation Tube market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Sodium Citrate Erythrocyte Sedimentation Tube market opportunities vary by end market size?
• How does Sodium Citrate Erythrocyte Sedimentation Tube break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Sodium Citrate Erythrocyte Sedimentation Tube by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Sodium Citrate Erythrocyte Sedimentation Tube by Country/Region, 2021, 2025 & 2032

  • 2.2 Sodium Citrate Erythrocyte Sedimentation Tube Segment by Type

    • 2.2.1 Glass

    • 2.2.2 PET Plastic

    • 2.2.3 Sodium Citrate Erythrocyte Sedimentation Tube Sales by Type

      • 2.2.3.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Sodium Citrate Erythrocyte Sedimentation Tube Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Sodium Citrate Erythrocyte Sedimentation Tube Sale Price by Type (2021-2026)

  • 2.3 Sodium Citrate Erythrocyte Sedimentation Tube Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Medical Laboratory

    • 2.3.3 Others

    • 2.3.4 Sodium Citrate Erythrocyte Sedimentation Tube Sales by Application

      • 2.3.4.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global Sodium Citrate Erythrocyte Sedimentation Tube Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global Sodium Citrate Erythrocyte Sedimentation Tube Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Breakdown Data by Company

    • 3.1.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Annual Sales by Company (2021-2026)

    • 3.1.2 Global Sodium Citrate Erythrocyte Sedimentation Tube Sales Market Share by Company (2021-2026)

  • 3.2 Global Sodium Citrate Erythrocyte Sedimentation Tube Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Revenue by Company (2021-2026)

    • 3.2.2 Global Sodium Citrate Erythrocyte Sedimentation Tube Revenue Market Share by Company (2021-2026)

  • 3.3 Global Sodium Citrate Erythrocyte Sedimentation Tube Sale Price by Company

  • 3.4 Key Manufacturers Sodium Citrate Erythrocyte Sedimentation Tube Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Sodium Citrate Erythrocyte Sedimentation Tube Product Location Distribution

    • 3.4.2 Players Sodium Citrate Erythrocyte Sedimentation Tube Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Sodium Citrate Erythrocyte Sedimentation Tube by Geographic Region

  • 4.1 World Historic Sodium Citrate Erythrocyte Sedimentation Tube Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Sodium Citrate Erythrocyte Sedimentation Tube Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Sodium Citrate Erythrocyte Sedimentation Tube Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Sodium Citrate Erythrocyte Sedimentation Tube Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Sodium Citrate Erythrocyte Sedimentation Tube Sales Growth

  • 4.4 APAC Sodium Citrate Erythrocyte Sedimentation Tube Sales Growth

  • 4.5 Europe Sodium Citrate Erythrocyte Sedimentation Tube Sales Growth

  • 4.6 Middle East & Africa Sodium Citrate Erythrocyte Sedimentation Tube Sales Growth

• 5 Americas

  • 5.1 Americas Sodium Citrate Erythrocyte Sedimentation Tube Sales by Country

    • 5.1.1 Americas Sodium Citrate Erythrocyte Sedimentation Tube Sales by Country (2021-2026)

    • 5.1.2 Americas Sodium Citrate Erythrocyte Sedimentation Tube Revenue by Country (2021-2026)

  • 5.2 Americas Sodium Citrate Erythrocyte Sedimentation Tube Sales by Type (2021-2026)

  • 5.3 Americas Sodium Citrate Erythrocyte Sedimentation Tube Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Sodium Citrate Erythrocyte Sedimentation Tube Sales by Region

    • 6.1.1 APAC Sodium Citrate Erythrocyte Sedimentation Tube Sales by Region (2021-2026)

    • 6.1.2 APAC Sodium Citrate Erythrocyte Sedimentation Tube Revenue by Region (2021-2026)

  • 6.2 APAC Sodium Citrate Erythrocyte Sedimentation Tube Sales by Type (2021-2026)

  • 6.3 APAC Sodium Citrate Erythrocyte Sedimentation Tube Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Sodium Citrate Erythrocyte Sedimentation Tube by Country

    • 7.1.1 Europe Sodium Citrate Erythrocyte Sedimentation Tube Sales by Country (2021-2026)

    • 7.1.2 Europe Sodium Citrate Erythrocyte Sedimentation Tube Revenue by Country (2021-2026)

  • 7.2 Europe Sodium Citrate Erythrocyte Sedimentation Tube Sales by Type (2021-2026)

  • 7.3 Europe Sodium Citrate Erythrocyte Sedimentation Tube Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Sodium Citrate Erythrocyte Sedimentation Tube by Country

    • 8.1.1 Middle East & Africa Sodium Citrate Erythrocyte Sedimentation Tube Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Sodium Citrate Erythrocyte Sedimentation Tube Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Sodium Citrate Erythrocyte Sedimentation Tube Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Sodium Citrate Erythrocyte Sedimentation Tube Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Sodium Citrate Erythrocyte Sedimentation Tube

  • 10.3 Manufacturing Process Analysis of Sodium Citrate Erythrocyte Sedimentation Tube

  • 10.4 Industry Chain Structure of Sodium Citrate Erythrocyte Sedimentation Tube

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Sodium Citrate Erythrocyte Sedimentation Tube Distributors

  • 11.3 Sodium Citrate Erythrocyte Sedimentation Tube Customer

• 12 World Forecast Review for Sodium Citrate Erythrocyte Sedimentation Tube by Geographic Region

  • 12.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Market Size Forecast by Region

    • 12.1.1 Global Sodium Citrate Erythrocyte Sedimentation Tube Forecast by Region (2027-2032)

    • 12.1.2 Global Sodium Citrate Erythrocyte Sedimentation Tube Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Sodium Citrate Erythrocyte Sedimentation Tube Forecast by Type (2027-2032)

  • 12.7 Global Sodium Citrate Erythrocyte Sedimentation Tube Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Becton Dickinson

    • 13.1.1 Becton Dickinson Company Information

    • 13.1.2 Becton Dickinson Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.1.3 Becton Dickinson Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Becton Dickinson Main Business Overview

    • 13.1.5 Becton Dickinson Latest Developments

  • 13.2 Greiner Bio-One

    • 13.2.1 Greiner Bio-One Company Information

    • 13.2.2 Greiner Bio-One Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.2.3 Greiner Bio-One Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Greiner Bio-One Main Business Overview

    • 13.2.5 Greiner Bio-One Latest Developments

  • 13.3 FL MEDICAL

    • 13.3.1 FL MEDICAL Company Information

    • 13.3.2 FL MEDICAL Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.3.3 FL MEDICAL Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 FL MEDICAL Main Business Overview

    • 13.3.5 FL MEDICAL Latest Developments

  • 13.4 KS Medical

    • 13.4.1 KS Medical Company Information

    • 13.4.2 KS Medical Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.4.3 KS Medical Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 KS Medical Main Business Overview

    • 13.4.5 KS Medical Latest Developments

  • 13.5 Deltalab

    • 13.5.1 Deltalab Company Information

    • 13.5.2 Deltalab Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.5.3 Deltalab Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Deltalab Main Business Overview

    • 13.5.5 Deltalab Latest Developments

  • 13.6 Orsin Medical Technology

    • 13.6.1 Orsin Medical Technology Company Information

    • 13.6.2 Orsin Medical Technology Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.6.3 Orsin Medical Technology Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Orsin Medical Technology Main Business Overview

    • 13.6.5 Orsin Medical Technology Latest Developments

  • 13.7 Xinkang Medical

    • 13.7.1 Xinkang Medical Company Information

    • 13.7.2 Xinkang Medical Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.7.3 Xinkang Medical Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Xinkang Medical Main Business Overview

    • 13.7.5 Xinkang Medical Latest Developments

  • 13.8 Xiangyuan Medical

    • 13.8.1 Xiangyuan Medical Company Information

    • 13.8.2 Xiangyuan Medical Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.8.3 Xiangyuan Medical Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Xiangyuan Medical Main Business Overview

    • 13.8.5 Xiangyuan Medical Latest Developments

  • 13.9 Tedia Medical Instruments

    • 13.9.1 Tedia Medical Instruments Company Information

    • 13.9.2 Tedia Medical Instruments Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.9.3 Tedia Medical Instruments Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Tedia Medical Instruments Main Business Overview

    • 13.9.5 Tedia Medical Instruments Latest Developments

  • 13.10 Boon Medical Supply

    • 13.10.1 Boon Medical Supply Company Information

    • 13.10.2 Boon Medical Supply Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.10.3 Boon Medical Supply Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Boon Medical Supply Main Business Overview

    • 13.10.5 Boon Medical Supply Latest Developments

  • 13.11 Improve Medical

    • 13.11.1 Improve Medical Company Information

    • 13.11.2 Improve Medical Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.11.3 Improve Medical Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Improve Medical Main Business Overview

    • 13.11.5 Improve Medical Latest Developments

  • 13.12 Ardent Biomed

    • 13.12.1 Ardent Biomed Company Information

    • 13.12.2 Ardent Biomed Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.12.3 Ardent Biomed Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Ardent Biomed Main Business Overview

    • 13.12.5 Ardent Biomed Latest Developments

  • 13.13 Gongdong Medical

    • 13.13.1 Gongdong Medical Company Information

    • 13.13.2 Gongdong Medical Sodium Citrate Erythrocyte Sedimentation Tube Product Portfolios and Specifications

    • 13.13.3 Gongdong Medical Sodium Citrate Erythrocyte Sedimentation Tube Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Gongdong Medical Main Business Overview

    • 13.13.5 Gongdong Medical Latest Developments

• 14 Research Findings and Conclusion